These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 30658726)
21. Kupffer cell pyroptosis mediated by METTL3 contributes to the progression of alcoholic steatohepatitis. Pan XS; Li BW; Wang LL; Li N; Lin HM; Zhang J; Du N; Zhu YQ; Wu X; Hu CM; Wu WY; Hou H; Zhao HC; Liao SY; Yang YN; Huang Y FASEB J; 2023 Jun; 37(6):e22965. PubMed ID: 37171272 [TBL] [Abstract][Full Text] [Related]
22. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218 [TBL] [Abstract][Full Text] [Related]
23. Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway. Mandal P; Pritchard MT; Nagy LE World J Gastroenterol; 2010 Mar; 16(11):1330-6. PubMed ID: 20238399 [TBL] [Abstract][Full Text] [Related]
24. Free radicals, chemokines, and cell injury in HIV-1 and SIV infections and alcoholic hepatitis. Bautista AP Free Radic Biol Med; 2001 Dec; 31(12):1527-32. PubMed ID: 11744325 [TBL] [Abstract][Full Text] [Related]
25. C-C chemokine receptor type 5 deficiency exacerbates alcoholic fatty liver disease through pro-inflammatory cytokines and chemokines-induced hepatic inflammation. Park JH; Lee DH; Park MS; Jung YS; Hong JT J Gastroenterol Hepatol; 2017 Jun; 32(6):1258-1264. PubMed ID: 27859576 [TBL] [Abstract][Full Text] [Related]
26. Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota. Liu H; Liu M; Fu X; Zhang Z; Zhu L; Zheng X; Liu J Nutrients; 2018 Sep; 10(9):. PubMed ID: 30217037 [TBL] [Abstract][Full Text] [Related]
27. Macrophages in the pathophysiology of NAFLD: The role of sex differences. Ministrini S; Montecucco F; Sahebkar A; Carbone F Eur J Clin Invest; 2020 Jun; 50(6):e13236. PubMed ID: 32294235 [TBL] [Abstract][Full Text] [Related]
28. An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac. Selvaraj S; Oh JH; Borlak J Arch Toxicol; 2020 Aug; 94(8):2733-2748. PubMed ID: 32372211 [TBL] [Abstract][Full Text] [Related]
30. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Roberts RA; Ganey PE; Ju C; Kamendulis LM; Rusyn I; Klaunig JE Toxicol Sci; 2007 Mar; 96(1):2-15. PubMed ID: 17122412 [TBL] [Abstract][Full Text] [Related]
31. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Bode C; Bode JC Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):166S-71S. PubMed ID: 16344604 [TBL] [Abstract][Full Text] [Related]
32. Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease. Hundertmark J; Krenkel O; Tacke F Front Immunol; 2018; 9():2418. PubMed ID: 30405618 [TBL] [Abstract][Full Text] [Related]
33. Purinergic P2X7 receptor blockade mitigates alcohol-induced steatohepatitis and intestinal injury by regulating MEK1/2-ERK1/2 signaling and egr-1 activity. Su QQ; Tian YY; Liu ZN; Ci LL; Lv XW Int Immunopharmacol; 2019 Jan; 66():52-61. PubMed ID: 30445307 [TBL] [Abstract][Full Text] [Related]
34. Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles. Hernández A; Geng Y; Sepúlveda R; Solís N; Torres J; Arab JP; Barrera F; Cabrera D; Moshage H; Arrese M Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165753. PubMed ID: 32126269 [TBL] [Abstract][Full Text] [Related]
36. Alcoholic liver disease: the gut microbiome and liver cross talk. Hartmann P; Seebauer CT; Schnabl B Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593 [TBL] [Abstract][Full Text] [Related]
37. Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease. Yang YM; Cho YE; Hwang S Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054960 [TBL] [Abstract][Full Text] [Related]
38. 22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXRα. Na TY; Han YH; Ka NL; Park HS; Kang YP; Kwon SW; Lee BH; Lee MO J Pathol; 2015 Apr; 235(5):710-20. PubMed ID: 25557254 [TBL] [Abstract][Full Text] [Related]
39. Microbiome as a therapeutic target in alcohol-related liver disease. Sarin SK; Pande A; Schnabl B J Hepatol; 2019 Feb; 70(2):260-272. PubMed ID: 30658727 [TBL] [Abstract][Full Text] [Related]
40. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. Sakaguchi S; Takahashi S; Sasaki T; Kumagai T; Nagata K Drug Metab Pharmacokinet; 2011; 26(1):30-46. PubMed ID: 21150132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]